ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2273

The Effect of Widespread Pain on Incident Knee Pain and Knee Osteoarthritis: The Multicenter Osteoarthritis (MOST) Study

Lisa Carlesso1,2, Neil Segal3, Jeffrey R. Curtis4, Barton L. Wise5, Laura Frey-Law6, Michael C. Nevitt7, Anyu Hu8 and Tuhina Neogi9, 1Division of Health Care & Outcomes Research, Toronto Western Research Institute, University Health Network, Toronto, ON, Canada, 2School of Rehabiliation, Maisonneuve Rosemont Research Institute, Université de Montréal, Montreal, QC, Canada, 3University of Kansas, Shawnee, KS, 4Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Int Medicine, UCDMC, Sacramento, CA, 6UIowa, Iowa City, IA, 7Epidemiology and Biostatistics, UCSF, San Francisco, CA, 8Clinical Epidemiology Research Unit, Boston University School of Medicine, Boston, MA, 9Clinical Epidemiology, BUSM, Boston, MA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Knee and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Epidemiology and Public Health Poster (ARHP)

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Widespread pain (WSP) may be present in individuals for numerous reasons, and its presence may affect the degree to which people engage in activities. How the presence of WSP affects the risk of developing knee pain or knee osteoarthritis (OA) is unknown and could enhance the understanding of pain mechanisms in OA. For example, people with WSP may have a lower risk of developing knee OA due to less frequent loading of the knee or they may have an increased risk due to maladaptive movement patterns. The purpose of this study was to determine if WSP is associated with future consistent frequent knee pain (CFKP) or radiographic OA (ROA) two years later.

Methods: Subjects from the Multicenter Osteoarthritis (MOST) study, a NIH-funded longitudinal prospective cohort of older adults with or at risk of knee OA were assessed at the 60-month (baseline) and 84-month (follow up) visits. WSP was defined at baseline as pain on both sides of the body, above and below the waist, and axial pain, using a standard homunculus, with the exception that the knees were not included in defining WSP. Incident CFKP was defined as reporting knee pain on most days during the past month at the 84-month telephone interview and again during the clinic visit that occurred on average one month later among participants who were free of CFKP at 60 months. Incident ROA was defined as presence of Kellgren & Lawrence grade 2 or knee replacement of either knee at follow-up among those who were free of ROA (and knee replacement) at baseline. We assessed the relation of WSP to risk of CFKP and ROA respectively, using multinomial regression adjusting for baseline age, sex, BMI, comorbidities, physical activity and clinic site; the model was also adjusted for depressive symptoms, pain catastrophizing, fatigue and ROA when CFKP was the outcome, and for WOMAC pain severity when ROA was the outcome.

Results:

There were 923 eligible subjects for analysis of incident CFKP (mean age (SD); 67.4 (7.5); BMI 30.0 (5.6) kg/m2, 56% women, 19% WSP), and 675 for incident ROA (age 65.6 (7.4); BMI 28.9 (4.7) kg/m2, 60% women, 30% WSP). Baseline presence of WSP was associated with a non-significant 59% increased risk of incident CFKP compared with those without WSP (adjusted OR 1.59, 95% CI 0.94-2.68, p=0.08). Baseline WSP was associated with a non-significant 14% lower risk of incident ROA, (adjusted OR 0.86, 95% CI 0.46-1.63, p=0.65). WSP was associated with a non-significant 65% increased risk of unilateral CFKP vs. no CFKP (adjusted OR 1.65, 95% CI 0.92-2.96, p=0.09) and with a non-significant 35% increased risk of bilateral CFKP vs. no CFKP (adjusted OR 1.35, 95% CI 0.49-3.73, p=0.56). For both incident unilateral and bilateral ROA vs. no ROA, WSP was not statistically significantly associated; unilateral ROA had 1% lower risk (adjusted OR 0.99, 95% CI 0.51-1.92, p=0.97), and bilateral ROA had 77% lower risk (adjusted OR 0.23, 95% CI 0.02-2.53, p=0.23).

Conclusion: WSP was not significantly associated with either incident CFKP or ROA. Development of knee pain and ROA does not appear to be influenced by underlying WSP, suggesting that screening for or managing WSP will not have a meaningful influence on the development of knee pain or ROA.


Disclosure: L. Carlesso, None; N. Segal, None; J. R. Curtis, Roche/Genentech, UCB, Janssen, CORRONA, Amgen, Pfizer, BMS, Crescendo, AbbVie, 2,Roche/Genentech, UCB, Janssen, CORRONA, Amgen, Pfizer, BMS, Crescendo, AbbVie, 5; B. L. Wise, None; L. Frey-Law, None; M. C. Nevitt, None; A. Hu, None; T. Neogi, None.

To cite this abstract in AMA style:

Carlesso L, Segal N, Curtis JR, Wise BL, Frey-Law L, Nevitt MC, Hu A, Neogi T. The Effect of Widespread Pain on Incident Knee Pain and Knee Osteoarthritis: The Multicenter Osteoarthritis (MOST) Study [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-effect-of-widespread-pain-on-incident-knee-pain-and-knee-osteoarthritis-the-multicenter-osteoarthritis-most-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-effect-of-widespread-pain-on-incident-knee-pain-and-knee-osteoarthritis-the-multicenter-osteoarthritis-most-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology